Targeting RAS -mutant Cancers: Is ERK the Key?

Trends in Cancer - Tập 1 - Trang 183-198 - 2015
Meagan B. Ryan1, Channing J. Der1,2, Andrea Wang-Gillam3, Adrienne D. Cox1,2,4
1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
3Division of Oncology, Department of Internal Medicine, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA
4Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Trends in Cancer

Tập 1

183-198

Thông tin tác giả